References
- Folkhälsomyndigheten (The Public Health Agency) Sweden. STRAMA: the Swedish strategic programme against antibiotic resistance. Behandlingsrekommendationer för vanliga infektioner i öppenvården. “Treatment recommendations for common infections in primary health care.” [accessed 2019 Nov 26]. 2019. Available from: https://www.folkhalsomyndigheten.se/publicerat-material/
- The Capital Region of Denmark. Komplicered cysitits – Antibiotikavejledning for primaersektorn Region Hovedstaden. Complicated cystitis – antibiotic treatment recommendations for primary health care – Captial Region of Denmark. [accessed 2019 Nov 26]. Available from: https://www.sundhed.dk/sundhedsfaglig/information-til-praksis/hovedstaden/almen-praksis/laegemidler/antibiotikavejledning/a07-urinveje/kompliceret-cystitis/
- Statens Serum Institut. DANMAP 2018 – Use of antimicrobial agents and occurrence of antimicrobialresistance in bacteria from food animals, food and humans in Denmark. 2019. ISSN 1600–2032.
- SWEDRES-SVARM 2018. Consumption of antibiotics and occurrence of resistance in Sweden. Solna/Uppsala. 2019. ISSN 1650–6332.
- Montelin H, Forsman KJ, Tangden T. Retrospective evaluation of nitrofurantoin and pivmecillinam for the treatment of lower urinary tract infections in men. PLoS One. 2019;14(1):e0211098.
- Jansaker F, Boel JB, Thonnings S, et al. Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not - a retrospective cohort study. Infect Drug Resist. 2019;12:1691–1702.
- Boel JB, Jansaker F, Hertz FB, et al. Treatment duration of pivmecillinam in men, non-pregnant and pregnant women for community-acquired urinary tract infections caused by Escherichia coli: a retrospective Danish cohort study. J Antimicrob Chemother. 2019;74(9):2767–2773.
- Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the infectious diseases society of America and the European society for microbiology and infectious diseases. Clin Infect Dis. 2011;52(5):e103–20.
- Jansaker F, Thonnings S, Hertz FB, et al. Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: a randomised, double-blind, placebo-controlled superiority trial. E Clin Med. 2019;12:62–69.
- Huttner A, Kowalczyk A, Turjeman A, et al. Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: a randomized clinical trial. JAMA. 2018;319(17):1781–1789.
- Kuula LSM, Viljemaa KM, Backman JT, et al. Fluoroquinolone-related adverse events resulting in health service use and costs: a systematic review. PLoS One. 2019;14(4):e0216029.